MedTrace Logo

Autologous Patch Healing vs. Secondary Intention Healing After Mohs Micrographic Surgery

NCT05170035 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2023-03-16

No results posted yet for this study

Summary

The primary objects of this study is to explore the potential effect of the autologous patch to optimize wound healing after skin cancer surgery with Mohs micrographic surgery (MMS) in the face in a randomized controlled trial comparing autologous patch healing versus secondary intention healing.

Conditions

Interventions

PROCEDURE

MMS + Autologous patch

A patch of consisting of platelets, leucocytes and fibrin, formed by the patients own blood sample.

PROCEDURE

MMS and secondary intention healing

Mohs micrographic surgery (standard of care) (wounds will heal by secondary intention healing)

Sponsors & Collaborators

  • Benzon Foundation

    collaborator UNKNOWN

  • Bispebjerg Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2024-02-29
Completion
2024-02-29

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05170035 on ClinicalTrials.gov